Search - tctmd.com

Displaying 981 - 1000 of 1071

Sort: Relevancy | Date

News Industry News

First Patient Enrolled in Medtronic-Supported Head-To-Head Clinical Trial Comparing Cryoballoon Ablation to RF Ablation for Paroxysmal Atrial Fibrillation

January 23, 2012

News Daily News

Comprehensive Exercise Therapy Program Motivates Physical Activity Post-PCI

Yael L. Maxwell

January 23, 2012

News Daily News

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

January 17, 2012

News Industry News

Bard Acquires Lutonix, Inc.

December 19, 2011

News Daily News

LIPSIA: No Rush for Treatment of High-Risk NSTEMI Patients

Leah Lawrence

December 08, 2011

News Daily News

Transcatheter Pulmonary Valve Prone to Stent Fracture

Jason Kahn

December 07, 2011

News Industry News

FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac Resynchronization Therapy with Defibrillator (CRT-D) Devices

December 07, 2011

News Industry News

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

November 21, 2011

News Industry News

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

November 15, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Industry News

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

November 10, 2011

News Industry News

Clinical trial of a new dual therapy stent establishes non-inferiority compared to paclitaxel-eluting stent

November 10, 2011

News Industry News

New analysis measures cost effectiveness of transcatheter aortic valve replacement compared to surgical valve replacement

November 09, 2011

News Industry News

St. Jude Medical Portico Transcatheter Valve Demonstrates Promising Results in Feasibility Study

November 09, 2011

News Industry News

Quality of Life and Economic Analyses of Edwards SAPIEN Valve in High-Risk Patients Featured at TCT

November 09, 2011

News Industry News

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

November 08, 2011

News Conference News

Preclinical Results Promising for Combo Stent

November 08, 2011

News Conference News

Low Event Rates with EES Sustained at 2 Years

November 08, 2011

News Conference News

EES Compared Favorably with SES In Two Pivotal Trials

November 08, 2011

News Conference News

SYNTAX at 4 Years: PCI and CABG Equivalent in Left Main Disease

November 07, 2011

Advertisement

First Patient Enrolled in Medtronic-Supported Head-To-Head Clinical Trial Comparing Cryoballoon Ablation to RF Ablation for Paroxysmal Atrial Fibrillation

Comprehensive Exercise Therapy Program Motivates Physical Activity Post-PCI

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

Bard Acquires Lutonix, Inc.

LIPSIA: No Rush for Treatment of High-Risk NSTEMI Patients

Transcatheter Pulmonary Valve Prone to Stent Fracture

FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac Resynchronization Therapy with Defibrillator (CRT-D) Devices

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

Clinical trial of a new dual therapy stent establishes non-inferiority compared to paclitaxel-eluting stent

New analysis measures cost effectiveness of transcatheter aortic valve replacement compared to surgical valve replacement

St. Jude Medical Portico Transcatheter Valve Demonstrates Promising Results in Feasibility Study

Quality of Life and Economic Analyses of Edwards SAPIEN Valve in High-Risk Patients Featured at TCT

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

Preclinical Results Promising for Combo Stent

Low Event Rates with EES Sustained at 2 Years

EES Compared Favorably with SES In Two Pivotal Trials

SYNTAX at 4 Years: PCI and CABG Equivalent in Left Main Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content